DexCom, Inc. vs Schlumberger NV — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV is far larger — about 2.4× DexCom, Inc.'s market cap, and Schlumberger NV pays a 2.2% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | SLB | |
|---|---|---|
Market Cap | $33.79B | $79.67B |
Sector | Health | Energy |
52-Week High | $89.53 | $58.01 |
52-Week Low | $54.84 | $31.72 |
Enterprise Value | $33.24B | $88.40B |
Dividend Yield | — | 2.2% |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →